Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. [PDF]
Zaitoon H +3 more
europepmc +1 more source
Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation. [PDF]
Maya J +11 more
europepmc +1 more source
Perioperative GLP-1 Receptor Agonist Use is Associated With Reduced Revisions and Complications Following ACDF: A Propensity-Matched Analysis. [PDF]
Kim MT, Lee S, Goh GS, Riew KD.
europepmc +1 more source
Efficacy and safety of orforglipron, an oral small-molecule GLP-1 receptor agonist, on cardiometabolic outcomes: a meta-analysis and systematic review. [PDF]
Alper A +6 more
europepmc +1 more source
Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis. [PDF]
Tzang CC +9 more
europepmc +1 more source
GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases.
Chi KY +5 more
europepmc +1 more source
Combination of GLP-1 receptor agonist and Akkermansia muciniphila Akk11 reduces adiposity and ameliorates MASLD in T2D mice. [PDF]
Gao K +13 more
europepmc +1 more source
Intractable Vomiting in the Setting of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist and Cannabis Usage. [PDF]
DesRochers P +4 more
europepmc +1 more source
GLP-1 Receptor Agonist Indications and Prescriptions Among Adults Who Do and Do Not Smoke. [PDF]
Leavens ELS +5 more
europepmc +1 more source
GLP-1 receptor agonists: differentiation within the class [PDF]
openaire +2 more sources

